Jones v. American Cyanamid

CourtCourt of Appeals for the Fourth Circuit
DecidedMarch 17, 1998
Docket97-1519
StatusUnpublished

This text of Jones v. American Cyanamid (Jones v. American Cyanamid) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jones v. American Cyanamid, (4th Cir. 1998).

Opinion

UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

LISA CAROLINE JONES; JOANNE JONES; JOHN M. JONES, Plaintiffs-Appellants, No. 97-1519 v.

AMERICAN CYANAMID COMPANY, Defendant-Appellee.

LISA CAROLINE JONES; JOANNE JONES; JOHN M. JONES, Plaintiffs-Appellees, No. 97-1607 v.

AMERICAN CYANAMID COMPANY, Defendant-Appellant.

Appeals from the United States District Court for the District of South Carolina, at Greenville. Henry M. Herlong, Jr., District Judge. (CA-94-1374-6-20)

Argued: January 30, 1998

Decided: March 17, 1998

Before HAMILTON and LUTTIG, Circuit Judges, and VOORHEES, Chief United States District Judge for the Western District of North Carolina, sitting by designation.

_________________________________________________________________ Affirmed in part and vacated in part by unpublished per curiam opin- ion.

_________________________________________________________________

COUNSEL

ARGUED: Marc Simon Moller, KREINDLER & KREINDLER, New York, New York, for Appellants. Roger William Yoerges, WIL- MER, CUTLER & PICKERING, Washington, D.C., for Appellee. ON BRIEF: Stanley P. Kops, KOPS & FENNER, Philadelphia, Pennsylvania, for Appellants. David P. Donovan, Brigida Benitez, John E. Smith, WILMER, CUTLER & PICKERING, Washington, D.C.; William S. Brown, NELSON, MULLINS, RILEY & SCAR- BOROUGH, Greenville, South Carolina, for Appellee.

_________________________________________________________________

Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).

_________________________________________________________________

OPINION

PER CURIAM:

Plaintiff-appellant Lisa Jones brought suit against defendant- appellee American Cyanamid claiming that she contracted polio through contact with an unknown individual who had recently been administered with a defective dose of polio vaccine manufactured by defendant. After discovery, the parties filed cross-motions for sum- mary judgment, both of which were granted in part and denied in part. Judgment was entered in favor of the defendant, however, because the district court granted summary judgment for defendant on the issue of causation, which, under South Carolina law, is an essential element of plaintiff's tort case. Both parties appeal. Because we conclude that plaintiff has not presented sufficient evidence tending to show that any alleged defect in defendant's polio vaccine caused her particular injury, we affirm the judgment entered in favor of the defendant. We

2 also vacate as moot the remaining elements of the judgment entered in favor of Jones.

Plaintiff-appellant claims that she contracted polio through contact with an unknown individual who had recently received a dose of defendant's defective polio vaccine. Specifically, plaintiff has pres- ented evidence that defendant American Cyanamid, acting in viola- tion of federal safety regulations, used an overly virulent type III "polio seed" to derive vaccine lots for type III polio. Plaintiff insists that this violation of federal regulations constituted negligence per se under South Carolina law. If this alleged negligence on the part of American Cyanamid were in fact the true cause of plaintiff's illness, then plaintiff would have contracted type III polio because there are three distinct types of polio and each one is caused only by a distinct type of poliovirus (types I, II, and III).

The district court entered summary judgment in favor of defendant on the issue of causation because Jones had failed to present any evi- dence tending to establish that it is more likely than not she contracted type III polio. The district court reasoned as follows:

During this case, it has been represented to the court that a determination of the specific type of polio is ascertainable only if doctors perform definitive tests at an early state in the onset of polio. Past a certain point in the progression of polio, it becomes impossible to determine with certainty which of the three types of polio is involved. . . .

Jones admits that there is no way to diagnose what spe- cific type of polio she has. Because definitive tests for polio were never performed on Jones at the onset of her illness, it is now impossible to determine with 100% accuracy whether she has type 3 polio.

Jones claims she has experts who will testify that, histori- cally, type 3 polio is the most common to arise from Cyan- amid's vaccine. Apparently, this testimony will be in the nature of statistics and the experts will assign a percentage to the likelihood that Jones has type 3 polio. Jones asks the court to apply the following reasoning: "Since most cases of

3 contact polio are Type III, and Type III is genetically the most unstable, with a history of neurovirulence, a jury could well infer it was the Type III component, in particular, that caused Lisa Jones' illness." As Cyanamid noted at the Feb- ruary 18, 1997 hearing, it has experts who will testify that type 1 or type 2 polio is more common in contact cases such as this one. . . .

Viewing the facts in the light most favorable to Jones, the court concludes that there is insufficient evidence for a jury to reasonably determine whether Jones has type 1, type 2, or type 3 polio. . . .

Jones does not have an expert who can say, based on Jones' medical history and medical data, that it is more probable than not that she suffers from type 3 polio. Even though that would be an impossible task, it would be inappropriate to allow a jury to make the logical leap from testimony that a certain percentage of polio victims have type 3 polio to the conclusion that Jones has type 3 polio. As a result, Jones is unable to sufficiently demonstrate that a reasonable jury could find that it is more probable than not that she has type 3 polio.

J.A. at 3432-34. While the district court appears to have based its con- clusion upon a view that statistical evidence cannot, as a matter of law, suffice to make a causation case, and while we are not convinced that South Carolina courts would refuse to allow plaintiffs to establish causation through statistical evidence, we nevertheless conclude the district court reached the proper conclusion in this case because plain- tiff has not presented any legally sufficient evidence -- medical his- tory evidence, statistical evidence, or other -- to create a triable issue of fact that it is more likely than not that Jones contracted type III polio.

Under South Carolina law, in a tort case "where a medical causa- tion issue is not one within the common knowledge of the layman," the plaintiff must present "medical expert testimony" in order to establish causation. Goewey v. United States, 886 F. Supp. 1268, 1279 (D.S.C. 1995). Clearly, whether plaintiff contracted type III

4 polio from defendant's allegedly defective vaccine is a causation question beyond the common knowledge of the layman, and plaintiff has not presented expert medical testimony sufficient to defeat sum- mary judgment on causation. First, plaintiff has presented no direct medical history evidence from any experts that she has type III polio. Plaintiff has designated ten experts, none of whom was designated to testify that Lisa Jones had type III polio. J.A. at 1190-1204, 1681-89. Furthermore, when Jones became ill in 1983, presumably before it became too late to determine what, if any, type of polio she had con- tracted, she was admitted to a hospital where she received extensive testing for polio, and neither blood tests, stool samples, nor cerebro- spinal fluid tests disclosed that she had type III polio. See J.A. 609-10, 668, 670, 672, 677, 679. In fact, although her treating physician referred to her paralysis as "polio-like," J.A.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bragg v. Hi-Ranger, Inc.
462 S.E.2d 321 (Court of Appeals of South Carolina, 1995)
Goewey v. United States
886 F. Supp. 1268 (D. South Carolina, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
Jones v. American Cyanamid, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jones-v-american-cyanamid-ca4-1998.